Anticonvulsant properties of N-salicyloyltryptamine in mice.
F A Oliveira, R N de Almeida, M F Sousa, J M Barbosa-Filho, S A Diniz, I A de Medeiros
Index: Pharmacol. Biochem. Behav. 68 , 199-202 , (2001)
Full Text: HTML
Abstract
A new tryptamine analogue, N-salicyloyltryptamine (STP), a potential central nervous system (CNS) depressant, was tested in the pentylenetetrazol (PTZ) and maximal electroshock (MES) models of epilepsy in mice. When administered concurrently, STP (100 mg/kg ip) significantly reduced the number of animals that exhibited PTZ-induced seizures and eliminated the extensor reflex of maximal electric-induced seizures test in 50% of the experimental animals. In addition, it showed protection in the PTZ test by diminishing the death rate.
Related Compounds
Related Articles:
2014-12-01
[Environ. Toxicol. Chem. 33(12) , 2671-8, (2014)]
2015-01-01
[Int. J. Nanomedicine 10 , 4937-46, (2015)]
2015-09-01
[Environ. Sci. Pollut. Res. Int. 22 , 14127-35, (2015)]
2015-07-01
[J. Clin. Invest. 125 , 2609-25, (2015)]
2014-01-01
[Audiol. Neurootol. 19(5) , 342-50, (2014)]